Cargando…
Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders
OBJECTIVE: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. METHODS: In 2014, the Alternating Hemiplegia of Childhood Foundati...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335249/ https://www.ncbi.nlm.nih.gov/pubmed/28293679 http://dx.doi.org/10.1212/NXG.0000000000000139 |
_version_ | 1782512007430275072 |
---|---|
author | Rosewich, Hendrik Sweney, Matthew T. DeBrosse, Suzanne Ess, Kevin Ozelius, Laurie Andermann, Eva Andermann, Frederick Andrasco, Gene Belgrade, Alice Brashear, Allison Ciccodicola, Sharon Egan, Lynn George, Alfred L. Lewelt, Aga Magelby, Joshua Merida, Mario Newcomb, Tara Platt, Vicky Poncelin, Dominic Reyna, Sandra Sasaki, Masayuki Sotero de Menezes, Marcio Sweadner, Kathleen Viollet, Louis Zupanc, Mary Silver, Kenneth Swoboda, Kathryn |
author_facet | Rosewich, Hendrik Sweney, Matthew T. DeBrosse, Suzanne Ess, Kevin Ozelius, Laurie Andermann, Eva Andermann, Frederick Andrasco, Gene Belgrade, Alice Brashear, Allison Ciccodicola, Sharon Egan, Lynn George, Alfred L. Lewelt, Aga Magelby, Joshua Merida, Mario Newcomb, Tara Platt, Vicky Poncelin, Dominic Reyna, Sandra Sasaki, Masayuki Sotero de Menezes, Marcio Sweadner, Kathleen Viollet, Louis Zupanc, Mary Silver, Kenneth Swoboda, Kathryn |
author_sort | Rosewich, Hendrik |
collection | PubMed |
description | OBJECTIVE: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. METHODS: In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with ATP1A3-related disorders. RESULTS: Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts. CONCLUSIONS: This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible ATP1A3 mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy. |
format | Online Article Text |
id | pubmed-5335249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-53352492017-03-14 Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders Rosewich, Hendrik Sweney, Matthew T. DeBrosse, Suzanne Ess, Kevin Ozelius, Laurie Andermann, Eva Andermann, Frederick Andrasco, Gene Belgrade, Alice Brashear, Allison Ciccodicola, Sharon Egan, Lynn George, Alfred L. Lewelt, Aga Magelby, Joshua Merida, Mario Newcomb, Tara Platt, Vicky Poncelin, Dominic Reyna, Sandra Sasaki, Masayuki Sotero de Menezes, Marcio Sweadner, Kathleen Viollet, Louis Zupanc, Mary Silver, Kenneth Swoboda, Kathryn Neurol Genet Article OBJECTIVE: ATP1A3-related neurologic disorders encompass a broad range of phenotypes that extend well beyond initial phenotypic criteria associated with alternating hemiplegia of childhood (AHC) and rapid-onset dystonia parkinsonism. METHODS: In 2014, the Alternating Hemiplegia of Childhood Foundation hosted a multidisciplinary workshop intended to address fundamental challenges surrounding the diagnosis and management of individuals with ATP1A3-related disorders. RESULTS: Workshop attendees were charged with the following: (1) to achieve consensus on expanded diagnostic criteria to facilitate the identification of additional patients, intended to supplement existing syndrome-specific diagnostic paradigms; (2) to standardize definitions for the broad range of paroxysmal manifestations associated with AHC to disseminate to families; (3) to create clinical recommendations for common recurrent issues facing families and medical care providers; (4) to review data related to the death of individuals in the Alternating Hemiplegia of Childhood Foundation database to guide future efforts in identifying at-risk subjects and potential preventative measures; and (5) to identify critical gaps where we most need to focus national and international research efforts. CONCLUSIONS: This report summarizes recommendations of the workshop committee, highlighting the key phenotypic features to facilitate the diagnosis of possible ATP1A3 mutations, providing recommendations for genetic testing, and outlining initial acute management for common recurrent clinical conditions, including epilepsy. Wolters Kluwer 2017-03-02 /pmc/articles/PMC5335249/ /pubmed/28293679 http://dx.doi.org/10.1212/NXG.0000000000000139 Text en Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Article Rosewich, Hendrik Sweney, Matthew T. DeBrosse, Suzanne Ess, Kevin Ozelius, Laurie Andermann, Eva Andermann, Frederick Andrasco, Gene Belgrade, Alice Brashear, Allison Ciccodicola, Sharon Egan, Lynn George, Alfred L. Lewelt, Aga Magelby, Joshua Merida, Mario Newcomb, Tara Platt, Vicky Poncelin, Dominic Reyna, Sandra Sasaki, Masayuki Sotero de Menezes, Marcio Sweadner, Kathleen Viollet, Louis Zupanc, Mary Silver, Kenneth Swoboda, Kathryn Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders |
title | Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders |
title_full | Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders |
title_fullStr | Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders |
title_full_unstemmed | Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders |
title_short | Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders |
title_sort | research conference summary from the 2014 international task force on atp1a3-related disorders |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335249/ https://www.ncbi.nlm.nih.gov/pubmed/28293679 http://dx.doi.org/10.1212/NXG.0000000000000139 |
work_keys_str_mv | AT rosewichhendrik researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT sweneymatthewt researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT debrossesuzanne researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT esskevin researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT ozeliuslaurie researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT andermanneva researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT andermannfrederick researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT andrascogene researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT belgradealice researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT brashearallison researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT ciccodicolasharon researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT eganlynn researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT georgealfredl researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT leweltaga researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT magelbyjoshua researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT meridamario researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT newcombtara researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT plattvicky researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT poncelindominic researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT reynasandra researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT sasakimasayuki researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT soterodemenezesmarcio researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT sweadnerkathleen researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT violletlouis researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT zupancmary researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT silverkenneth researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders AT swobodakathryn researchconferencesummaryfromthe2014internationaltaskforceonatp1a3relateddisorders |